Amedica, has announced its partnership with Acquisition Aesthetics Training Academy training in Ameela Skin.
Amedica has teamed up with Acquisition Aesthetic Training Academy, to supply Polynucleotide-specific training courses for delegates in 2024, prioritising understanding the science behind Ameela Polynucleotides, learning multiple treatment techniques, treatment safety and how to achieve best possible results.
Ameela is a viscoelastic, sterile, non-pyrogenic, absorbable intradermal injectable solution, based on polynucleotides from wild salmon. It is well known for its high patient safety and is vastly becoming an alternative to tear-trough filler, due to its formulation and treatment techniques.
“Acquisition Aesthetics is delighted to launch polynucleotides training courses in collaboration with Amedica in 2024.” Says co-founder and chief executive of Acquisition Aesthetics, Dr Lara Watson, “By combining the innovative rejuvenation technology of Ameela with gold-standard approaches to aesthetics training and mentorship, Acquisition Aesthetics will be supporting practitioners in delivering holistic treatment plans and enhanced results to their patients. A recipe for sustainable success for any aesthetician – both clinically and commercially.”
Linn Emilie, founder of Amedica, says, “At Amedica, our mission has always been to lead with pioneering innovation and uncompromising quality. It is this spirit of excellence that aligns us with Acquisition Aesthetic, whose commitment to outstanding and safe educational practices resonates with our core values. This synergy has forged a partnership that is set to elevate the training landscape, ensuring that practitioners administering Ameela treatments are not only skilled but also visionaries in their field.”
